For example, IDH1 mutation has been reported to exert a greater prognostic relevance in glioblastoma and anaplastic astrocytoma than histological grade, indicating that molecular markers might potentially supersede histological grade in tumor classification [27]. This evidence concerns the gene IDH1 and glioblastoma.